A possible drawback is the high frequency of GSTP1 methylation in patients with high-grade prostatic intraepithelial neoplasia (HG PIN) and in patients with negative or suspicious PB. This evidence concerns the gene GSTP1 and prostate intraepithelial neoplasia.